Our Core Team
Bruce Clarke, Founder
Bruce founded Selkirk Strategy Consultants, Inc. in 2004, after over a decade of biopharmaceutical industry experience in sales, marketing and business analysis roles. Since the founding of Selkirk, Bruce has advised and managed on numerous diverse engagements, including market assessments, licensing opportunity identification and screening, strategic due diligence, commercialization planning, and forecasting. His clients include emerging and established biotechnology and pharmaceutical companies across numerous therapeutic areas.
Prior to Selkirk, Bruce managed the market research & analytics department at QLT, Inc., spending five years working on drug development, product and business development assessments. Prior to that, Bruce was at Schering-Plough Corporation and managed market research and sales analytics in the Allergy and Asthma division. He has also held sales and marketing positions at Schering-Plough.
Lisa Meyr, Director
Lisa joined Selkirk Strategy Consultants, Inc. in 2008 and brings an extensive background in the sciences, including BS and MS degrees in organic chemistry and four years as a medicinal chemist at Exelixis, Inc. Lisa supplemented this scientific knowledge with an MBA from the Foster School of Business, University of Washington. Lisa has worked with many companies including: Frazier Healthcare Ventures, Genentech (Pipeline and Portfolio Planning), Allozyne and Seattle Biomedical Research Institute. Additionally, she participated in the UW Business Plan Competition (winning award for ‘best technology’).
o Lisa brings a diverse skill set in both sciences and business and has worked with many different types of life science companies spanning from the bench to the boardroom.
Learn about Selkirk's extended team of consultants
